chrisvoncsefalvay/vaers-outcomes huggingface dataset:
fully vaccinated with the Pfizer vaccine/patient tested positive in April; fully vaccinated with the Pfizer vaccine/patient tested positive in April; This is a spontaneous report from a non-contactable consumer via a Pfizer sales representative. This consumer reported similar events for 3 patients. This is the second of three reports.   A 42-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date in 2021 (Lot number was not reported) as 2nd dose, single and via an unspecified route of administration on an unspecified date in 2021 (Lot number was not reported) as 1st dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was fully vaccinated with the Pfizer vaccine and tested positive on Apr2021. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on Apr2021. The patient did not require hospitalization and self- treated at home with an unspecified treatment. The outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021539650 same reporter, same drug, similar event, different patient;US-PFIZER INC-2021539614 same reporter, same drug, similar event, different patient
5/23 chills,headache, sore throat, diarheah, vomiting, cough, low energy 5/24 Seen doctor given steriod and antibiotic injections, prescribed prednisone and antibiotics.   Condition improved for a few days but never went away. Then condition started to worsen as  energy and breathining became worse. condition continued to decline as breathing becomes more labored and energy level dropped more. had to stop working as condition worsend. couldnt walk 20 feet without having to stop and rest. i was out of breath and struggling. decided to see doctor again. 6/17 seen doctor and given steriod and antibiotic injections again.  given new scripts for prednisone and antibiootics. condition did not improve. more to add
Possible ejection of needle into muscle. Patient X-ray done at ER revealing no injury.
I had just finished a one hour walk and was feeling great when I arrived at the pharmacy for my booster vaccine at 11 a.m. By  6 p.m. I had a sore throat, cough, and swelling in my left arm. I was sick all weekend. I know the vaccine is not supposed to give you a sore throat, but this one did. How do I know? When I have a "regular" sore throat there's a gradual build up to it. I just don't suddenly have a sore throat. I also have the exact same sore throat I had in March 2020 when I thought I had covid - fever, shortness of breath, sore throat, cough -- but I did not qualify back then for a test because of the shortage of tests available. Don't tell me this is just a coincidence. I got covid symptoms from this shot. Next step is to get tested to see if I actually have covid. I may get a false positive because of the symptoms.
Shingles after second dose of the COVID Vaccine; This is a spontaneous report from a contactable consumer or other non-healthcare professional. This contactable consumer reported about co-workers sister. This report is 2 of 2. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration, on unspecified date, as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration, on unspecified date, as dose 1, single for COVID-19 immunization. Patient experienced shingles after her second dose of the COVID Vaccine and now worried about getting the third dose. Patient recently lost her father to COVID 19. And patient works as a dental hygienist. The clinical outcome of event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
tasted very bad and appeared oily; not able to swallow full dose due to spitting out; not able to swallow full dose due to spitting out; This non-serious case was reported by a nurse via sales rep and described the occurrence of regurgitation of medication in a 4-month-old male patient who received Rota (Rotarix lyophilized formulation) (batch number SKBYL9YN) for prophylaxis. This case was associated with a product complaint.   On 21-APR-2023, the patient received Rotarix lyophilized formulation. On 21-APR-2023, less than a day after receiving Rotarix lyophilized formulation, the patient experienced regurgitation of medication (Verbatim: not able to swallow full dose due to spitting out) and accidental underdose (Verbatim: not able to swallow full dose due to spitting out). On an unknown date, the patient experienced pharmaceutical product complaint (Verbatim: tasted very bad and appeared oily). The outcome of the regurgitation of medication, accidental underdose and pharmaceutical product complaint were unknown.   It was unknown if the reporter considered the regurgitation of medication to be related to Rotarix lyophilized formulation and Rotarix Oral Applicator Device.   It was unknown if the company considered the regurgitation of medication to be related to Rotarix lyophilized formulation and Rotarix Oral Applicator Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 21-APR-2023 The patient was not able to swallow full dose of Rotarix liquid due to spitting out. It was observed that the vaccine tasted very bad and appeared oily as it dribbled out of the corners of the mouth. The patient did not receive a second dose.  The patient made face as if it tasted too bad to swallow. The patient previously had used Rotarix vial presentation and had no problems. The reporter agreed to follow up from GlaxoSmithKline.  The patient was not able to swallow full dose of Rotarix liquid due to spitting out and observed that the vaccine tasted very bad and appeared oily as it dribbled out of the corners of the mouth, which led to accidental underdose and pharmaceutical product complaint. This was 1 of 12 linked cases, reported by the same reporter.; Sender's Comments:  US-GSK-US2023AMR059645:Same Reporter US-GSK-US2023AMR058971:Same Reporter US-GSK-US2023AMR059807:Same reporter US-GSK-US2023AMR059644:Same reporter US-GSK-US2023AMR058971:Same reporter US-GSK-US2023AMR060400:Same reporter US-GSK-US2023AMR059645:Same reporter US-GSK-US2023AMR060497:Same reporter US-GSK-US2023AMR060491:Same reporter US-GSK-US2023AMR060460:Same reporter US-GSK-US2023AMR060463:Same reporter US-GSK-US2023AMR060476:Same reporter
Patient presented to the ED and was subsequently hospitalized for CVA within 6 weeks of receiving covid vaccination booster.
Approximately 3 hours post vax, the pt experienced respiratory symptoms (asthma like) over the next several hours which progressed systemically, severe headache, nausea, vomiting, chills, fever of 102. Treated with Tylenol, Benadryl and ventolin inhaler.
about 5 minutes after vaccine administered, patient reported right hand feeling  numb and pain at injection site.  30 minutes  after injection she felt dizzy.  Symptoms decreased and she was returned to work after 45 minutes of monitoring.  Later felt "palpitations" and lightheaded--she went to ED approximately 10 pm for evaluation
pt walked over to pharmacy counter, got lightheaded, was leaned up against wall and started to slouch down, pharmacy technician helped to lay him on the floor, I came over and took pulse, and blood pressure, called 911 with pt permission at 10:15am.  Pt was conscious the whole time I was present and aware of situation, time ,date, location. EMS arrived around 10:25 checked pt over and pt went on.
Caller reports multiple doses of VAXELIS administered since temperature excursion; This spontaneous report with reference numbers 02197725 / 02197588 was received by partner on 05-JUL-2022 and forwarded on 06-JUL-2022 from a consumer.    The causal relationship between Vaxelis and the reported event "multiple doses of VAXELIS administered since temperature excursion" was assessed as not applicable due to the nature of the event.    Further information is expected.
Urticaria 5-10 minutes after administration of DTaP and flu vaccine. Benadryl given - hives resolved in 30 minutes.
Mother phoned the clinic today and states daughter's upper left arm has been swollen since yesterday and has a knot under the skin since receiving a shot in that arm on Tuesday, 3/4/03.
I have an autoimmune flare up, GI flare up. Two days after my vaccine, my symptoms got worse. My auto immune flared up really bad and intensified on 08-31-2021. I had body aches, joint pain, redness and swelling in my fingers. I also get tongue pain and lip pain and lip swelling. I also got eye lid swelling. My auto immune flare is still present.
Fever 102.3 , chills, body aches, headache, tachypnea,. All symptoms started 19 hours after injection. Besides that, soreness & swelling at injection site.
Pt is a 50 y.o. male  who presented to a HCF on 9/20 for worsening SOA. He initially tested positive for COVID19 on 9/13. He was on BiPAP at the hospital but continued to have increasing O2 requirements. He was intubated on 9/23 for worsening hypoxia and transferred to another medical center for further management.  In the ICU, the patient was continued on mechanical ventilation and appropriately weaned. Patient self-extubated on 9/26 to a third HCF. He developed thick secretions/fevers on 9/24 and was treated with a 5 day course of cefepime. He completed his dexamethasone course.
Pt developed a rasied, red, patchy rash, similar to hives, size of a softball on thigh on 1/19/15. Pt said it was painful. Pt said rash is still there, improving but still there.
This is a spontaneous report from a contactable Nurse Practitioner via a Pfizer sales representative. This nurse reported the same event for 2 patients. This is the 2nd of two reports. A patient of an unspecified age, gender and race received TRUMENBA for Immunisation at 0.5ml single dose on unknown date via intramuscular route. No concomitant medications, other medical conditions, or testing/investigations known at this time. Within an hour of receiving the first dose of vaccine, on unknown date, the patient experienced pain, headache, vomiting and dizziness. The patient went to the Emergency Room. The outcome of the events was unknown. Sender's Comments: Linked Report(s): US-PFIZER INC-2017465772 Same reporter/drug/event, different patients.
Information has been received from a nurse referring to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with a dose of improperly stored PNEUMOVAX23 (lot # L033707, expiration date 18-MAY-2017, route unknown). The vaccine had been stored under 50.9 Fahrenheit for 34 minutes. There was no previous exposures. No adverse effects were reported.  This is one of several reports received from the same reporter. Additional information has been requested.
Received the first dose of Pfizer's COVID vaccine on 29Mar2021. He tested positive for COVID and is now symptom free for 14 days.; Received the first dose of Pfizer's COVID vaccine on 29Mar2021. He tested positive for COVID and is now symptom free for 14 days.; This is a spontaneous report received from a contactable consumer (reporting on himself). A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VAC-CINE, Formulation: solution for injection, Lot Number and Expiration Date was not reported), via an unspecified route of administration on 29Mar2021 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient received the first dose of BNT162B2 vaccine on 29Mar2021. He tested positive for COVID and is now symptom free for 14 days. patient was wondering if it was ok for him to receive his second dose on Monday 19Apr2021. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Eye pressure in both eyes risen unexpectedly, today eye pressure was 13 and 16; Discomfort in eye; This spontaneous case was reported by a consumer and describes the occurrence of OCULAR DISCOMFORT (Discomfort in eye) and INTRAOCULAR PRESSURE INCREASED (Eye pressure in both eyes risen unexpectedly, today eye pressure was 13 and 16) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced OCULAR DISCOMFORT (Discomfort in eye). On 30-Mar-2021, the patient experienced INTRAOCULAR PRESSURE INCREASED (Eye pressure in both eyes risen unexpectedly, today eye pressure was 13 and 16). At the time of the report, INTRAOCULAR PRESSURE INCREASED (Eye pressure in both eyes risen unexpectedly, today eye pressure was 13 and 16) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Vaccine was given at 1130am, at 1132 employee reported she was feeling short of breath, she was diaphoretic and her face and neck were bright red in color. SHe sat in chair, placed fan with cool air facing her. CHecked Blood pressure 147/87, HR 100, Sats 98%, reassess blood pressure in 3 minutes blood pressure 132/78, HR 92, Sats 98%. Reports she was feeling better and returned to work. at 1500 she reports feeling back to normal. The following day employee sent email stating she wazs not feeling well and had went to her provider. Provider suggested to fill out adverse raction form.
Child experienced fever to 106 < 24 hrs p/DTP/MMR immun on 30SEP89 & screaming for > 4 hrs. To ER; 10OCT89 pt still has low grade fever-on antibiotics. 26OCT89 still running low fever. MD suspects child has virus. Not to rec'd DTP again.
Patient said that within a few hours of receiving the vaccination he felt serious soreness, which turned into limited range of motion (basically none) and extreme pain by late evening.  Patient took Ibuprofen 400 mg the following day and range of motion returned and reported decrease in pain.
Encephalopathy; A spontaneous report was received from a physician concerning a patient, unknown age or gender, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced encephalopathy.  No medical history was reported. No concomitant medications were provided.  The patient received both of the two planned doses of mRNA-1273 (Lot numbers not provided) intramuscularly for prophylaxis of COVID-19 infection on an unknown dates.  On an unknown date, the patient experienced encephalopathy. No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in response to the event is not applicable.   The outcome of the event, encephalopathy, was unknown.; Reporter's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
weakness,could not get out of bed, he does not have energy; sleep at night is different,does not get a restful sleep; symptoms escalated over the course of 4 days; extreme fatigue,tiredness,wiped out for a good 3 to 4 hours; achiness,muscle pain; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness,could not get out of bed, he does not have energy), SLEEP DISORDER (sleep at night is different,does not get a restful sleep), CONDITION AGGRAVATED (symptoms escalated over the course of 4 days), FATIGUE (extreme fatigue,tiredness,wiped out for a good 3 to 4 hours) and MYALGIA (achiness,muscle pain) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B212A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cholesterol, Chronic pain, Diabetes and Fibromyalgia. Concomitant products included SIMVASTATIN for Cholesterol, INSULIN LISPRO (HUMALOG) and INSULIN GLARGINE (LANTUS) for Diabetes, TRAMADOL for Pain, LEVOTHYROXINE SODIUM (SYNTHROID) and LEVOTHYROXINE for Thyroid therapy, OXYCODONE, FISH OIL, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (weakness,could not get out of bed, he does not have energy), SLEEP DISORDER (sleep at night is different,does not get a restful sleep), CONDITION AGGRAVATED (symptoms escalated over the course of 4 days), FATIGUE (extreme fatigue,tiredness,wiped out for a good 3 to 4 hours), MYALGIA (achiness,muscle pain) and ARTHRALGIA (joint pain). At the time of the report, ASTHENIA (weakness,could not get out of bed, he does not have energy), SLEEP DISORDER (sleep at night is different,does not get a restful sleep), CONDITION AGGRAVATED (symptoms escalated over the course of 4 days), MYALGIA (achiness,muscle pain) and ARTHRALGIA (joint pain) outcome was unknown and FATIGUE (extreme fatigue,tiredness,wiped out for a good 3 to 4 hours) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications includes Oxycodone short acting along with above mentioned medications. Treatment medication reported includes Oxycodone ER, Oxycodone short acting, and Tramadol.
This is a spontaneous report from a non-contactable consumer (Patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Lot Number: Unknown; Expiration Date: Unknown), via an unspecified route of administration, administered in Arm Left on 30Sep2021, as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. Medical history included Hashimotos Disease from an unknown date and unknown if ongoing. Concomitant medication(s) included influenza vaccine (FLU) taken for an unspecified indication, start and stop date were not reported received other vaccine in fourweeks. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Lot Number: Unknown; Expiration Date: Unknown) on an unspecified date as Dose 1, single and also received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Lot Number: Unknown; Expiration Date: Unknown) administered in arm right on 24Mar2021 as Dose 2, single for COVID-19 Immunization and dose 2 experienced severe flu like symptoms for two days and headache. No known allergies were reported. Prior to vaccination, patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. On 30Sep2021, booster dose - swelling in lymph node in armpit on same side of shot (immunisation). On 02Oct2021, the patient experienced booster dose - swelling in lymph node in armpit on same side of shot (lymphadenopathy). The patient did not received any treatment for event booster dose - swelling in lymph node in armpit on same side of shot (lymphadenopathy). The clinical outcome of the event not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Tinnitus tripled in severity/ Loud noise is uncomfortable; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Tinnitus tripled in severity/ Loud noise is uncomfortable) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046821A and 047A21A) for COVID-19 vaccination.     Concurrent medical conditions included Tinnitus (10 years history of mild tinnitus) and Enlarged prostate. Concomitant products included TAMSULOSIN for Enlarged prostate.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced TINNITUS (Tinnitus tripled in severity/ Loud noise is uncomfortable). At the time of the report, TINNITUS (Tinnitus tripled in severity/ Loud noise is uncomfortable) had not resolved.            Immediately after second dose, patient's tinnitus tripled in severity and had not gone down at all. It made patient's hearing very sensitive, loud noise was uncomfortable. Patient had not sought any treatment.
pt recv vax; 2 days later, low grade fever of 100 then sz began;
Developed Covid between his first and second dose; Developed Covid between his first and second dose; This is a spontaneous report from a contactable consumer. A male patient in his late 70s/ early 80s received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number unknown) via an unspecified route of administration on an unspecified date, at single dose for COVID-19 immunisation. Relevant medical history included some underlying health issues. Concomitant medications were not reported. Concomitant medications were not reported. The patient developed COVID between his first and second dose, on an unspecified date. The outcome of the event was unknown. The reporter was unsure about what brand of vaccine the patient received.  Information about batch/lot number has been requested.
This spontaneous report as received from the pharmacy technician refers to a patient of unknown gender and age. Information about the patient's medical history and concurrent condition was not provided. On an unknown date, the patient was vaccinated with the second dose of GARDASIL (dose, lot/batch#, expiration date were not reported) 6 months after receiving the first dose of GARDASIL. No adverse experience was reported. It was reported that the patient was not from the reporter's pharmacy. Additional information has been requested.
pt recvd MMR vax 22FEB91 & following vax pt devel t100, h/a, nausea, vomiting; pt hospitalized for sx;
Received varicella vaccine on 06/03/02 local redness, swelling, tenderness at site inj area. Unable to raise arm. Pain axilla, chest hurting day after immunization.
Passed out after giving MENACTRA. Dr called to room. Pulse and BP monitored vital signs stable. Color improved. Left without incident.
Extreme brain fog an hour after vaccine, moderate pain in armpit of vaccine arm, extreme muscle soreness day after vaccine (can't walk), 99.6 fever, heart rate in 90s all day while laying down (55 resting), mild headache, extreme fatigue
Headache; Sore arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and VACCINATION SITE PAIN (Sore arm at the injection site) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Sep-2021, the patient experienced HEADACHE (Headache) and VACCINATION SITE PAIN (Sore arm at the injection site). At the time of the report, HEADACHE (Headache) and VACCINATION SITE PAIN (Sore arm at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by the reporter. Treatment information was not provided. Patient's second dose was scheduled on 29-Sep-2021 at 09:45 am.